With antimicrobial resistance a rising global crisis, western medicine’s interest is turning to phage therapy as an alternative to antibiotics. Challenging past uncertainty in phage therapy’s commercial viability, recent developments such as highly positive results of compassionate use cases in the US has excited the field and the next step is successful phase II clinical trials.
Phage Futures Congress is a translational phage therapy conference where Steffanie Strathdee, Tom Patterson, the FDA, and others will discuss how we move phage therapy forward in the US. A number of A Smaller Flea authors will be speaking or in attendance: Jessica Sacher of Phage Directory, Ben Chan of Yale Univeristy, Shawna McCallin of PhageForward. I am pleased to announce that I have also joined the Scientific Advisory Board for the congress
Take a look at the agenda here.
A Smaller Flea 